Section Arrow
Quote
ALUR.NYSE
- Allurion Technologies
(Financial Status)
Quotes are at least 15-min delayed:2025/08/26 16:46 EDT
After Hours
Last
 2.3
+0.116 (+5.31%)
Bid
2
Ask
2.3
High 2.3 
Low 2.3 
Volume 500 
Regular Hours
Last
 2.184
-0.056 (-2.50%)
Day High 
2.2618 
Prev. Close
2.24 
1-M High
3.06 
Volume 
42.99K 
Bid
2
Ask
2.3
Day Low
2.15 
Open
2.22 
1-M Low
1.98 
Market Cap 
16.71M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.32 
20-SMA 2.54 
50-SMA 2.65 
52-W High 22.245 
52-W Low 1.98 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-10.13/2.06
Enterprise Value
53.76M
Balance Sheet
Book Value Per Share
-8.58
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
32.11M
Operating Revenue Per Share
8.35
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4303-0.0596-12.17%-- 
After Hours 0.45 +0.0197 +4.58%
PTHLPheton Holdings Ltd0.6689+0.1033+18.26%-- 
After Hours 0.6637 -0.0052 -0.78%
ABTAbbott Laboratories131.59-0.28-0.21%16.55PE
After Hours 131.59 0 0.00%
BFLYButterfly Network1.59+0.04+2.58%-- 
After Hours 1.59 0 0.00%
MDTMedtronic plc92.18+0.14+0.15%25.5PE
After Hours 92.18 0 0.00%
Quotes are at least 15-min delayed：2025/08/26 16:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.